Impact of Hospital Readmission on Quality of Life in AML | Ayobami Olafimihan, MD | #ASH24

Impact of Hospital Readmission on Quality of Life in AML | Ayobami Olafimihan, MD | #ASH24
Good Responses to Phase 2 CLIA + Ven Therapy for Acute Myeloid Leukemia | Tapan Kadia, MD | #ASH24
Good Responses to Phase 2 CLIA + Ven Therapy for Acute Myeloid Leukemia | Tapan Kadia, MD | #ASH24
Menin Inhibitor Study Results: Ziftomenib for Newly Diagnosed AML Patients | Amer Zeidan, MBBS | #ASH24
Menin Inhibitor Study Results: Ziftomenib for Newly Diagnosed AML Patients | Amer Zeidan, MBBS | #ASH24
VEN + IVO + AZA Combination Therapy in IDH1-Mutated AML, MDS & MPNs | Jennifer Marvin Peek, MD | #ASH24
VEN + IVO + AZA Combination Therapy in IDH1-Mutated AML, MDS & MPNs | Jennifer Marvin Peek, MD | #ASH24
CAR-T Cell Therapy for Transformed Follicular Lymphoma | Matthew Cortese, MD | #ASH24
CAR-T Cell Therapy for Transformed Follicular Lymphoma | Matthew Cortese, MD | #ASH24